A multicenter, randomized, double-blind, placebocontrolled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia
- 31 March 1996
- Vol. 47 (3) , 335-342
- https://doi.org/10.1016/s0090-4295(99)80449-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- TerazosinDrugs & Aging, 1993
- Quantitative analyses of human prostatic .ALPHA.-adrenoceptors and effects of terazosin on the .ALPHA.-adrenoceptor activity.Journal of Smooth Muscle Research, 1991
- Medical management of benign prostatic hyperplasiaUrology, 1990
- The Efficacy of Transurethral Resection of the Prostate in Men with Moderate Symptoms of ProstatismJournal of Urology, 1990
- Transurethral Prostatectomy: Practice Aspects of the Dominant Operation in American UrologyJournal of Urology, 1989
- Transurethral Prostatectomy: Immediate and Postoperative Complications. A Cooperative Study of 13 Participating Institutions Evaluating 3,885 PatientsJournal of Urology, 1989
- Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomyJAMA, 1987
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978
- Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder NeckBritish Journal of Urology, 1975